title: Melanoma resistance: a bright future for academicians and a challenge for patient advocates.
authors.affiliation: Department of Pathology and Laboratory Medicine, University of Tennessee Health Sciences Center, Memphis, TN; Department of Medicine, University of Tennessee Health Sciences Center, Memphis, TN. Electronic address: aslominski@uthsc.edu.
authors.forename: Andrzej T
authors.initials: AT
authors.lastname: Slominski
authors.affiliation: Department of Pathology and Laboratory Medicine, Albany Medical College, Albany, NY.
authors.forename: J Andrew
authors.initials: JA
authors.lastname: Carlson
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005260:Female; D012739:Gonadal Steroid Hormones / Q000276:immunology*; D006801:Humans; D056747:Immunomodulation / Q000502:physiology*; D007167:Immunotherapy / Q000379:methods*; D008297:Male; D008545:Melanoma / Q000276:immunology* / Q000556:secondary* / Q000628:therapy*; D058990:Molecular Targeted Therapy / Q000379:methods*; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000276:immunology*; D012878:Skin Neoplasms / Q000276:immunology* / Q000628:therapy*
chemical_list: D012739:Gonadal Steroid Hormones